Neurocrine Bioscience buy Needham & Company LLC
Start price
22.09.25
/
50%
€124.40
Target price
22.09.26
€144.89
Performance (%)
-3.09%
Price
14:38
€120.55
Summary
This prediction is currently active. With a performance of -3.09%, the BUY prediction for Neurocrine Bioscience by Needham___Company_LL is down slightly. This prediction currently runs until 22.09.26. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Neurocrine Bioscience | -3.662% |
| iShares Core DAX® | 0.696% |
| iShares Nasdaq 100 | 0.033% |
| iShares Nikkei 225® | -0.420% |
| iShares S&P 500 | 0.153% |
Comments by Needham___Company_LL for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NASDAQ:NBIX) had its price target raised by analysts at Needham & Company LLC from $161.00 to $170.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Needham___Company_LL for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€112.35
06.05.25
06.05.25
€123.07
06.05.26
06.05.26
6.54%
14:38
14:38
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€86.30
15.04.25
15.04.25
€121.87
15.04.26
15.04.26
38.70%
14:38
14:38